Filing Details

Accession Number:
0000935836-25-000324
Form Type:
13D Filing
Publication Date:
2025-05-12 20:00:00
Filed By:
Logos Capital
Company:
Olema Pharmaceuticals Inc.
Filing Date:
2025-05-13
SEC Url:
13D Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Logos Global Management LP 0 3,208,875 0 3,208,875 3,208,875 4.7%
Logos Global Management GP LLC 0 3,208,875 0 3,208,875 3,208,875 4.7%
Arsani William 0 3,208,875 0 3,208,875 3,208,875 4.7%
Graham Walmsley 0 3,208,875 0 3,208,875 3,208,875 4.7%
Logos Opportunities GP LLC 0 708,114 0 708,114 708,114 1.0%
Logos GP LLC 0 2,508,114 0 2,508,114 2,508,114 3.7%
Filing





If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. Checkbox not checked

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D



Comment for Type of Reporting Person:
Percentage calculated based on 68,333,065 shares of Common Stock outstanding on March 13, 2025, as reported in the Form 10-K filed by the Issuer for the fiscal year ended December 31, 2024.


SCHEDULE 13D



Comment for Type of Reporting Person:
Percentage calculated based on 68,333,065 shares of Common Stock outstanding on March 13, 2025, as reported in the Form 10-K filed by the Issuer for the fiscal year ended December 31, 2024.


SCHEDULE 13D



Comment for Type of Reporting Person:
Percentage calculated based on 68,333,065 shares of Common Stock outstanding on March 13, 2025, as reported in the Form 10-K filed by the Issuer for the fiscal year ended December 31, 2024.


SCHEDULE 13D



Comment for Type of Reporting Person:
Percentage calculated based on 68,333,065 shares of Common Stock outstanding on March 13, 2025, as reported in the Form 10-K filed by the Issuer for the fiscal year ended December 31, 2024.


SCHEDULE 13D



Comment for Type of Reporting Person:
Percentage calculated based on 68,333,065 shares of Common Stock outstanding on March 13, 2025, as reported in the Form 10-K filed by the Issuer for the fiscal year ended December 31, 2024.


SCHEDULE 13D



Comment for Type of Reporting Person:
Percentage calculated based on 68,333,065 shares of Common Stock outstanding on March 13, 2025, as reported in the Form 10-K filed by the Issuer for the fiscal year ended December 31, 2024.


SCHEDULE 13D

 
Logos Global Management LP
 
Signature:/s/ Arsani William
Name/Title:Managing Partner
Date:05/13/2025
 
Logos Global Management GP LLC
 
Signature:/s/ Arsani William
Name/Title:Managing Member
Date:05/13/2025
 
Arsani William
 
Signature:/s/ Arsani William
Name/Title:Reporting person
Date:05/13/2025
 
Graham Walmsley
 
Signature:/s/ Graham Walmsley
Name/Title:Reporting person
Date:05/13/2025
 
Logos Opportunities GP LLC
 
Signature:/s/ Arsani William
Name/Title:Managing Member
Date:05/13/2025
 
Logos GP LLC
 
Signature:/s/ Arsani William
Name/Title:Managing Member
Date:05/13/2025